The application process for obtaining a Medical Device Registration Certificate (MDRC) from the National Medical Products Administration (NMPA) in China is a structured and detailed process. Here's an overview of the key steps involved:
Classification Determination: Determine the classification of your medical device according to NMPA's classification rules (Class I, II, or III).
Quality Management System (QMS): Establish and document a QMS that complies with Chinese regulations. This system is crucial for demonstrating control over device design, production, and quality assurance.
Technical Documentation: Prepare comprehensive technical documentation, including device description, design and manufacturing information, risk management documentation, testing and validation data, and clinical evaluation (if required).
Testing: Conduct testing according to relevant Chinese national standards or NMPA recognized international standards. Obtain test reports from NMPA-accredited laboratories.
Clinical Evaluation (if required): For higher-risk devices (Class II and III), clinical evaluation data may be necessary to demonstrate safety and efficacy. This involves conducting clinical trials or providing clinical literature review data.
Online Submission: Prepare and submit the registration application through the NMPA's online registration platform. Include all required technical documentation, test reports, clinical data (if applicable), and evidence of QMS implementation.
Application Review: The NMPA will review the submitted documentation. This process may include detailed technical review, assessment of clinical data (if applicable), and evaluation of QMS compliance.
Technical Review: Regulatory experts at the NMPA will evaluate the technical documentation to ensure compliance with Chinese regulatory requirements.
Inspection: Depending on the device classification and risk level, the NMPA may conduct on-site inspections of manufacturing facilities to verify QMS implementation and production capabilities.
Local Representation: Engage a qualified Authorized Representative (AR) in China to facilitate communication with the NMPA and ensure compliance with local regulatory requirements.
Consultation: Consider consulting with local regulatory experts or consultants familiar with the NMPA registration process to navigate complexities and ensure timely submission and approval.
The NMPA application process is rigorous and requires careful attention to detail and compliance with Chinese regulatory standards. Preparation, documentation accuracy, and adherence to timelines are crucial for a successful registration outcome.
Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn